(NASDAQ: EYEN), an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ophthalmic suspension 0.05% (“Clobetasol”), approved by ...

23, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, toda Presentation details efficacy and tolerability results from the successful Phase 3 program that led ...

Credit: Antonio Guillem/Shutterstock. Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise clobetasol propionate ophthalmic ...

Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise clobetasol propionate ophthalmic suspension, 0.05% (APP13007), for post ...

Chardan is acting as sole placement agent for the offering.

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi ® for mydriasis. Eyenovia has also ...

Squeaking or creaking noises from your suspension can be annoying but they could also be a sign that there's a problem developing with your car. If you're distracted by sounds when you move over ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi ® for mydriasis. Eyenovia has also secured ...